Phase II Trial of Celebrex in Photodynamic Therapy (C-PDT) for Neovascular Age-related Macular Degeneration (AMD): Rationale and Baseline Characteristics
Go back to Resources
Phase II Trial of Celebrex in Photodynamic Therapy (C-PDT) for Neovascular Age-related Macular Degeneration (AMD): Rationale and Baseline Characteristics
Authors:
Location:
Go back to Resources